Loading viewer...
earnings
Format: PDF earnings
Teva Pharmaceutical Industries presented fourth quarter and full year 2022 financial results on February 8, 2023, detailing performance across its generic and specialty pharmaceutical portfolio including products such as AUSTEDO, AJOVY, and COPAXONE. The presentation addresses key business challenges including competition in generic markets, substantial debt management, and ongoing litigation matters.
investor_presentation
37 Pages
earnings
25 Pages
Walmart
A1 Telekom Austria 2021 Full Year Results
earningsearnings
44 Pages
A1 Telekom Austria Group
CSAV FY 2021 Financial Results - Hapag-Lloyd Performance
earningsearnings
32 Pages
Compañía Sud Americana de Vapores